Univalent Antibody Fragments Research Articles

The Clinical Potential of Circulating Tumor Cells; The Need to Incorporate a Modern “Immunological Cocktail” in the Assay

The accepted clinical assay, CellSearch®, and lab-on-a-chip tests for capturing circulating tumor cells are antibody-mediated. Attempts to improve their sensitivity have relied upon physical changes in the instruments. There have been no significant advances in improving the antibody-mediated portion of the capture. Modern immunologic engineering offers major possibilities for improving the sensitivity and other features of the assay. These include obtaining univalent antibody fragments such as scFvs with picomolar binding affinity and sufficient specificity; altering them to enhance their range of potential contact with target antigens; using antibodies directed against different epitopes on epithelial, mesenchymal or organ-specific cell surface markers to allow simultaneous binding and investigating non-antibody binding molecules as substitutes for antibody. These maneuvers could markedly improve the ability of current assays to improve patient care and might result in an acceptable test for detecting cancer earlier in high risk patients.

Generation of Sequence-specific, High Affinity Anti-DNA Antibodies

By taking advantage of the extreme stability of a protein-DNA complex, we have obtained two highly specific monoclonal antibodies against a predetermined palindromic DNA sequence corresponding to the binding site of the E2 transcriptional regulator of the human papillomavirus (HPV-16). The purified univalent antibody fragments bind to a double-stranded DNA oligonucleotide corresponding to the E2 binding site in solution with dissociation constants in the low and subnanomolar range. This affinity matches that of the natural DNA binding domain and is severalfold higher than the affinity of a homologous bovine E2 C-terminal domain (BPV-1) for the same DNA. These antibodies discriminate effectively among a number of double- and single-stranded synthetic DNAs with factors ranging from 125- to 20,000-fold the dissociation constant of the specific DNA sequence used in the immunogenic protein-DNA complex. Moreover, they are capable of fine specificity tuning, since they both bind less tightly to another HPV-16 E2 binding site, differing in only 1 base pair in a noncontact flexible region. Beyond the relevance of obtaining a specific anti-DNA response, these results provide a first glance at how DNA as an antigen is recognized specifically by an antibody. The accuracy of the spectroscopic method used for the binding analysis suggests that a detailed mechanistic analysis is attainable.

High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor

Univalent antibody fragments directed against the main immunogenic region (MIR) of the human acetylcholine receptor (AChR) are capable of protecting the AChR against loss induced by antibodies from myasthenia gravis (MG) patients. Our aim was to construct single-chain Fv (scFv) antibody fragments as a first step towards the production of therapeutic protecting molecules, from two high-affinity anti-MIR monoclonal antibodies (mAb 192 and mAb 195). During the construction of scFv192 fragment, two light chains co-secreted from the hybridoma mAb192 were identified. N-terminal amino acid and cDNA sequence analysis showed that one of the two light chains corresponded to the antigen binding molecule while the other originated from the non-secreting myeloma S194/5.XXO.BU.1 which was used in the production of the hybridoma. Functional scFv 192 and 195 fragments were constructed, expressed in Escherichia coli and affinity purified. The binding affinities of scFv192 and scFv195 ( K D=0.6 and 0.8 nM for human AChR) were two orders of magnitude higher than that of the earlier constructed scFv198. The scFv192 almost completely protected human AChR against binding of intact anti-MIR mAbs. Human AChR was also very efficiently protected (74–85%) by the scFv192 against binding of autoantibodies from MG sera with high anti-α subunit antibody fractions. These scFvs are good candidates for protection of MG patients after appropriate genetic modifications.

Bacterial expression of immunoglobulin fragments

The expression of Ig fragments in Escherichia coli permits rapid access to engineered molecules with antigen-binding properties. While the expression in a functional state by secretion to the periplasm is the standard method for the production of Fv and Fab fragments, single chain Fv fragments are mainly produced by refolding from insoluble aggregates. Although all of these Ig fragments serve as valuable aids in the study of antigen binding, their different biochemical properties must be considered when using them as research tools or for medical applications. In addition to these simple univalent antibody fragments, the bacterial expression of bivalent and bispecific versions and of hybrid proteins with novel effector functions is gaining increasing importance.

Ponticulin, a developmentally‐regulated plasma membrane glycoprotein, mediates actin binding and nucleation

Ponticulin is a 17,000-dalton transmembrane glycoprotein that is involved in the binding and nucleation of actin filaments by Dictyostelium discoideum plasma membranes. The major actin-binding protein isolated from these membranes by F-actin affinity chromatography, ponticulin also binds F-actin on blot overlays. The actin-binding activity of ponticulin in vitro is identical to that observed for purified plasma membranes: it resists extraction with 0.1 N NaOH, is sensitive to high salt concentrations, and is destroyed by heat, proteolysis, and thiol reduction and alkylation. A cytoplasmic domain of ponticulin mediates binding to actin because univalent antibody fragments directed against the cytoplasmic surface of this protein inhibit 96% of the actin-membrane binding in sedimentation assays. Antibody specific for ponticulin removes both ponticulin and the ability to reconstitute actin nucleation activity from detergent extracts of solubilized plasma membranes. Levels of plasma membrane ponticulin increase 2- to 3-fold during aggregation streaming, when cells adhere to each other and are highly motile. Although present throughout the plasma membrane, ponticulin is preferentially localized to some actin-rich membrane structures, including sites of cell-cell adhesion and arched regions of the plasma membrane reminiscent of the early stages of pseudopod formation. Ponticulin also is present but not obviously enriched at phagocytic cups of log-phase amebae. These results indicate that ponticulin may function in vivo to attach and nucleate actin filaments at the cytoplasmic surface of the plasma membrane. A 17,000-dalton analogue of ponticulin has been identified in human polymorphonuclear leukocyte plasma membranes by immunoblotting and immunofluorescence microscopy.(ABSTRACT TRUNCATED AT 250 WORDS)

Enhancement of bovine growth hormone activity in vivo by monoclonal antibodies

Monoclonal antibodies (MAbs) prepared against ovine growth hormone (oGH) and recognizing several distinct or related specificities on bovine growth hormone (bGH), have been shown to strikingly enhance the growth promoting properties of the hormone in vivo as determined by 35SO 2− 4 incorporation in cartilage. The phenomenon is dependent on both hormone and antibody dose and is saturable in the presence of excess antibody. Competition binding analysis between pairs of antibodies has shown that they define distinct antigenic regions on bGH of which one is represented by four MAbs. The most potent growth enhancement was associated with a group of three MAbs (OA11, OA12 and OA13) binding to topographically closely related sites. Another MAb (OA14) with a specificity similar to OA11 and OA13 as defined by competition assay failed to enhance bGH activity. Two antibodies binding to a further two sites (OA15 and OA16) demonstrated modest growth enhancement activity when in complex with bGH, whereas the binding of another antibody (OA17) did not significantly affect hormonal activity. Univalent antibody fragments (Fab) derived from MAb OA11 were equi-potent to the bivalent form of the antibody in the enhancement of bGH activity. Determination of the effects of the different MAbs on the binding of 125I-bGH to liver microsome receptors revealed substantial increase in specific binding (3.5-fold) and is associated with some growth enhancing MAbs. However, not all growth enhancing MAbs increased receptor binding and in the case of one, OA16, clear cut inhibition of receptor binding was observed. Tentative conclusions have been drawn on the possible underlying mechanisms of the MAb mediated enhancement phenomenon.

Chapter 20 Cell Adhesion: Its Quantification, Assay of the Molecules Involved, and Selection of Defective Mutants in Dictyostelium and Polysphondylium

Cells of Dictyostelium discoideum adhere to substrata such as glass or plastic surfaces, to bacteria, to each other, and to cells of related species. These various contact interactions have different biological functions and different specificities. Adhesion to substratum is a prerequisite of movement of single cells and of their chemotactic response during aggregation. Attachment of bacteria precedes their phagocytosis and is important for nutrition of D.discoideum cells if the bacteria are suspended rather than fixed to a substratum. Homotypic cell–cell adhesion is involved in the aggregation process and in the maintenance of multicellularity in the slug and culmination stages. The chapter describes methods applicable to either one of these contact interactions and presents the cell adhesion in a related species, Polysphondylium pallidum . In the currently used methods, coulter counting and agglutinometer assays, the agglutination of suspended cells under conditions of constant shear are determined. One strategy to identify molecules involved in intercellular adhesion is based on the use of univalent antibody fragments (Fab) against total membrane antigens for the blockage of intercellular adhesion.

Potentiation of the somatogenic and lactogenic activity of human growth hormone with monoclonal antibodies

Monoclonal antibodies of certain epitope specificity have been shown to produce a marked dose-dependent enhancement of the somatogenic and lactogenic activity of human GH (hGH). Two antibodies (EB1 and EB2), binding to distinct antigenic determinants and expressed on both hGH and human chorionic somato-mammotrophin (hCS), significantly enhanced the hGH-stimulated uptake of 35S-labelled sulphate into cartilage. Similarly, these antibodies enhanced the lactogenic activity of both hGH and hCS in the pigeon crop sac test. Two hGH specific monoclonal antibodies (QA68 and NA71), defining a further two epitopes, exhibited only modest enhancing or inhibitory activity in these assays, whereas the binding of certain combinations of monoclonal antibodies resulted in either reversal of enhancement or inhibition of hormone activity. Univalent antibody fragments derived from EB1 were as enhancing as the intact antibody indicating that bivalency dependent mechanisms were not involved in the phenomenon. Enhancing monoclonal antibodies were relatively poor inhibitors of 125I-labelled hGH binding to liver microsomal receptors, which is in contrast with their previously described property of potent suppression of hGH interaction with lymphoid cell receptors. It is tentatively concluded that 'restriction' of hormone binding to particular hGH receptors, relevant to somatic growth or lactogenic activity, may play a role in the enhancement phenomenon of hGH in vivo.

The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages.

The interaction between the macrophage and the parasite plays a central role in the continued success of Leishmania infection. The promastigote surface ligand, and its complementary macrophage membrane receptor, involved in attachment and phagocytosis are likely to exert considerable influence over the outcome of a new infection. In this study, we report experiments pertaining to one such parasite membrane protein. Initial examination of promastigote surface proteins by radiolabeling and two-dimensional-polyacrylamide gel electrophoresis revealed an abundant polypeptide with an apparent m.w. of 63,000. Lectin-binding studies indicated that it was a glycoprotein containing mannose, N-acetyl glucosamine, and N-acetyl galactosamine residues. Monospecific antiserum raised against this glycoprotein, gp63, decorated the entire promastigote plasmalemma. Univalent antibody fragments from this antiserum blocked the interaction between promastigotes and macrophages by inhibiting attachment. Anti-gp63-inhibition reduced parasite/macrophage binding to 30 to 35% of the control binding level. Additional evidence of the involvement of gp63 in attachment to macrophages was provided by studies that made use of gp63-containing proteoliposomes. These vesicles were avidly phagocytosed by macrophages. Uptake of the gp63-containing liposomes was suppressed by greater than 90% by both anti-gp63 F(ab) fragments and the oligosaccharide mannan, indicating that their phagocytosis was receptor dependent. These results demonstrate that the abundant glycoprotein gp63 plays an important role in attachment of promastigotes to macrophages, and attachment via this parasite ligand is sufficient to trigger phagocytosis.

Platelet-collagen adhesion: evidence for participation of antigenically distinct entities.

Univalent antibody fragments prepared from a rabbit antiserum raised against whole human platelets completely inhibited adhesion of platelets to immobilized trimeric collagen in a defined, Mg2+-dependent, adhesion assay. An octylglucoside extract of whole platelets completely neutralized this antibody, and all neutralizing activity bound to immobilized wheat germ agglutinin. Further fractionation on concanavalin A gave rise to subfractions that each neutralized only partially at saturation, when tested against antibody concentrations that inhibit 50% of platelet-collagen adhesion. When tested against higher antibody concentrations that completely inhibited adhesion, each subfraction had no detectable neutralizing effect, although the combined subfractions neutralized completely. This and other evidence suggests that more than one platelet entity participates in platelet-collagen adhesion. Although distinct, they appear to play interdependent roles in a single adhesion process.

Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb.

To identify platelet surface structures involved in adhesion to collagen, the effect of 16 murine antiplatelet membrane hybridoma antibodies were tested in a defined, in vitro assay. Four of these antibodies inhibited platelet-collagen adhesion and reacted with a polypeptide with Mr approximately 125,000, as determined by immunoblots after gel electrophoresis under reducing conditions. Through detailed studies with one of these antibodies, the monoclonal antibody PMI-1, the relevant antigen was identified as platelet glycoprotein IIb alpha, based upon (a) co-migration with this glycoprotein in two-dimensional gel electrophoresis and (b) co-purification by immunoaffinity chromatography with a protein with apparent Mr identical to that of glycoprotein III, under conditions in which glycoproteins IIb and III form a complex. Univalent antibody fragments prepared from monoclonal antibody PMI-1 inhibited greater than 80% of platelet-collagen adhesion, and inhibition was completely blocked by the immunopurified antigen. These results indicate that glycoprotein IIb participates in some aspect of platelet-collagen adhesion. In contrast, the purified antigen only partially neutralized a polyclonal antiserum that blocked platelet-collagen adhesion, to a maximum of approximately 25%, at saturating antigen concentrations. Thus, by these immunological criteria, glycoprotein IIb is not the only molecule involved in this process.

Nerve growth factor (NGF) stimulation of cholinergic telencephalic neurons in aggregating cell cultures

The addition of nerve growth factor (2.5S NGF) to serum-free aggregating cell cultures of fetal rat telencephalon greatly stimulated the developmental increase in choline acetyltransferase activity. Two other neuronal enzymes, acetylcholinesterase and glutamic acid decarboxylase, showed only slightly increased activities after NGF treatment whereas the total protein content of the cultures and the activity of 2′,3′-cyclic nucleotide phosphodiesterase remained unchanged. The stimulation of choline acetyltransferase was dependent on the NGF media concentrations, showing a 50% maximum effect (120% increase) at approximately 3 ng/ml (10 −10 M 2.5S NGF). NGF treatments during different culture periods showed that the cholinergic neurons remained responsive for at least 19 days. The continued treatment was the most effective; however, an initial treatment for only 5 days still caused a significant stimulation of choline acetyltransferase on day 19. The observed stimulation appeared to be specific to NGF. Univalent antibody fragments (Fab) against 2.5S NGF completely abolished the NGF-dependent increase in choline acetyltransferase activity, whereas Fab fragments of control IgG were ineffective. Furthermore, angiotensin II, added in high amounts to the cultures, showed no stimulatory effect. The present results suggest that certain populations of rat brain neurons are responsive to nerve growth factor.

Characterization of a purified cell surface glycoprotein as a contact site in Polysphondylium pallidum

Target sites of adhesion-blocking univalent antibody fragments (Fab) were purified from membranes of Polysphondylium pallidum cells and their developmental regulation was studied. The major target site extractable with butanol-water proved to be a dimerizing glycoprotein. Monoclonal antibodies raised against this glycoprotein were used for antigen localization on the cell surface, and for affinity purification of the glycoprotein. Whereas the glycoprotein was present in both growth phase and aggregation-competent cells, a second target site of adhesion blocking Fab partially purified seemed to be a developmentally regulated protein. Quantitative data on Fab absorption by the two purified antigens were interpreted to indicate that more than one species of Fab must bind to the cell surface in order to substantially inhibit cell adhesion.

Nonantibody binding of serum proteins to 5S anti-Rh fragments produced by chymotrypsin.

Chymotrypsin hydrolysis of the IgG anti-Rh antibodies Ri results in both bivalent and univalent antibody fragments. The bivalent fragments coated on Rh-positive erythrocytes are agglutinable by albumin and other serum proteins in 3% polyethylene glycol. The bivalent structure of the 5S fragment is essential for expression of this site since 5S fragments produced by trypsin and pepsin are also agglutinable, while univalent fragments produced by papain and subtilisin are not. The agglutination by albumin of the 5S fragments is not caused by residual enzyme. The reaction appears to be irreversible in that once albumin has reacted with the 5S fragment, either in the fluid phase or at the cell surface, fresh addition of albumin and PEG will not result in agglutination. The nonantibody reaction of albumin and the other serum proteins with these 5S IgG fragments is believed to be caused by hydrophobic bonding involving the intrachain disulfide in the 5S fragment and hydrophobic areas of other proteins.

Endogenous cell surface lectin in Dictyostelium: quantitation, elution by sugar, and elicitation by divalent immunoglobulin.

The amount of total endogenous cellular and cell surface lectin in aggregating Dictyostelium purpureum was determined by a number of immunochemical techniques. The results show that of the 5 x 10(6) molecules of the lectin (called purpurin) per aggregating cell only about 2% (1 x 10(5) molecules) is present on the cell surface. Cell surface purpurin can be specially eluted by lactose, which indicates that it is held to the surface by its carbohydrate-binding site. The eluted purpurin is replaced on the cell surface within 45 min. Estimates of cell surface purpurin made by binding of specific immunoglobulin to the cells at 4 degrees C indicate that a much larger amount, about 1 x 10(6) molecules, becomes associated with the cell surface in the presence of this divalent ligand. In contrast, univalent antibody fragments do not have this effect.

Chapter 11 Univalent Antibody Fragments as Tools for the Analysis of Cell Interactions in Dictyostelium

Publisher Summary Labeled antibodies are routinely used in developmental biology for the localization of antigens and for their quantitative determination. Antibodies can, however, also be applied as probes that inhibit or stimulate developmental processes by interaction with specific cell surface constituents. This chapter focuses on this aspect. Intact immunoglobulins, when applied to living cells, have the disadvantage of agglutinating cells and inducing antigen redistribution in the form of patches and caps. This can be avoided by the use of univalent antibody fragments. In 1959, papain digestion was used that is the standard technique for the preparation of antigen binding fragments (Fab). Because the cells in Dictyosteliurn discoideurn (Dd) are single at the beginning of development and aggregate thereafter, this microorganism is unusually suitable for the analysis of cell interactions by Fab. Studies on cell adhesion in the neuroretina of the chicken among sea urchin blastomeres and in mammalian embryos have demonstrated that techniques similar to those described in the chapter for Dd can be applied to a variety of embryonic systems. The main conclusion from the use of Fab as an adhesion blocking agent is that processes essential for cell-to-cell adhesion are linked to specific loci on the cell surface. The antigenic material present at these loci covers only a small fraction of the surface area rather than forming a continuous surface coat. Fab molecules can bind to other surface sites in comparatively large numbers without blocking adhesion.

Comparison of developmentally regulated lectins from three species of cellular slime mold

Extracts of the cohesive forms of the cellular slime molds Dictyostelium discoideum, Dictyostelium mucoroides and Dictyostelium purpureum contain lectin activity, assayed as hemagglutination activity. The lectin activity from each species binds quantitatively to Sepharose 4B and can be eluted with d-galactose. The resultant purified lectins are abundant proteins representing, in the case of D. purpureum, up to 5% of the total soluble protein of cohesive cells. The preparations from each species are similar but distinct in amino acid composition and other properties. Each purified preparation gives rise to two protein bands on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with the major band representing as little at 77% ( D. purpureum) and as much as 96% ( D. mucoroides) of the total protein in the two bands. The molecular weights of the pair of bands were different for each species, ranging between about 23 000 and 26 000. The two bands are believed to represent subunits of lectins made up of either one or a combination of these two proteins. The apparent molecular weights of the purified lectin activities determined by sucrose density gradient centrifugation were all in the range of 100 000. N- Acetyl- d-galactosamine was a potent inhibitor of the hemagglutination activity of each preparation; but there were some differences in the relative inhibitory potency of a number of other saccharides. Antiserum raised against each preparation, as well as univalent antibody fragments derived from these antisera, reacted best with the antigens to which they were raised; but showed some cross reaction measured both by precipitin reactions and by inhibition of hemagglutination activity of the purified lectins. The differences between the lectins from the different species could be trivial; but they also could be important for defining specific properties of these three species which reliably segregate into colonies of a single species when grown in mixed culture.

A specific glycoprotein as the target site of adhesion blocking Fab in aggregating Dictyostelium cells.

During the acquisition of aggregation competence a new antigen appears on the surface of Dictyostelium cells. Univalent antibody fragments (Fab) against this antigen render the cells unable to form the specific type of cell adhesion which is characteristic of aggregating cells. This membrane constituent has been purified and identified as a concanavalin A-binding glycoprotein present at about 2 X 10(5) copies per cell.

Contact sites in aggregating cells of Polysphondylium pallidum

Aggregating cells of the cellular slime mold Polysphondylium pallidum are completely dissociated by univalent antibody fragments (Fab) directed against membrane antigens. The blocking effect on cell adhesion is species specific: Fab against P. pallidum has little effect on cells of Dictyostelium discoideum, and vice versa. Suspended cells of these species agglutinate together, but within the agglutinates they sort out into separate areas. Absorption of the Fab with growth phase cells removes only part of its blocking activity. This indicates the expression of a new class of target sites of adhesion blocking Fab during cell differentiation from the growth phase to the aggregation competent stage. Another class of target sites is already present on the surface of growth phase cells. In both developmental stages cell adhesion is largely resistant to EDTA. The major target sites of adhesion blocking Fab appear to differ from carbohydrate-binding proteins known as pallidin. Removal of the adhesion blocking activity by absorption of Fab with intact cells does not deplete for anti-pallidin Fab. Cell adhesion is only weakly affected by Fab specific for pallidin I and II.

Tetrahymena pyriformis recovers from antibody immobilisation by producing univalent antibody fragments

MANY protozoa possess mechanisms by which they are able to recover from immobilisation by specific antibodies. Paramecia have been shown to shed their ciliar antigens in response to specific divalent antibodies. After shedding the antibody bound antigens the animals present new antigens of different specificity1. It has been suggested that this modulation process also has a role in antigen variation in trypanosomes2. While modulation of serotypes in Tetrahymena pyriformis is primarily provoked by temperature shifts or changes in culture conditions3, induction of modulation in response to antibody agglutination has been reported4,5. Tetrahymena recovery from antibody provoked immobilisation has also been reported to occur by a nonspecific process not involving a change in serotype. Immobilised animals have been shown to secrete a substance which permits their recovery and protects animals of unrelated serotype from homologous anti-serum6–8. We have further examined the way that Tetrahymena recover from antibody provoked immobilisation. This process, which we call fabulation, apparently involves the proteolytic cleavage of both bound and free immunoglobulin to produce univalent fragments which bind or remain bound to the ciliar antigens and protect the animals from further antibody treatment with no apparent effects on cell growth. The cleavage seems to be catalysed by both cell bound and secreted proteases.